| Financial Year |
March 31 2023 |
| Monetary Funds |
1,669,609,801.51 |
| Held-for-trading Financial Assets |
212,792,963.57 |
| Notes Receivable |
9,397,148.06 |
| Accounts Receivable |
1,016,592,339.12 |
| Advances to Suppliers |
67,311,170.42 |
| Other Receivables |
99,193,848.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,200,000.00 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,338,052.14 |
| Total Current Assets |
3,125,485,465.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,290,474.90 |
| Investment Properties |
-- |
| Fixed Assetes |
205,292,417.77 |
| Under-construction Projects |
6,014,271.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,352,292.06 |
| R&D expenses |
-- |
| Goodwill |
135,373,649.10 |
| Long-Term Deferred and Prepaid Expenses |
12,885,787.40 |
| Deferred Income Tax Assets |
27,460,789.44 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
702,208,586.87 |
| Total Assets |
3,827,694,052.55 |
| Short-Term Loans |
435,490,727.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
644,636,453.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
108,524,211.86 |
| Taxes Payable |
11,516,100.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,015,280.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
192,657,397.92 |
| Other Current Liabilities |
274,653.19 |
| Sub-Total of Current Liabilities |
1,461,699,697.55 |
| Long-term Loans |
61,676,990.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
275,442,938.75 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,913,290.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
537,419,507.07 |
| Total Liabilities |
1,999,119,204.62 |
| Paid-In Capital(Or Share Stock) |
205,235,237.00 |
| Capital Surplus |
520,159,738.93 |
| Surplus Reserve |
49,519,845.35 |
| LESS:Treasury Stock |
1,868,939.33 |
| Undistributed Profits |
1,002,832,314.75 |
| Minority Stockholder's Interest |
49,854,143.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,778,720,704.21 |
| Owner's Equity（Stockholder's Equity） |
1,828,574,847.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,827,694,052.55 |
